Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Boston Scientific Corp | 41 |
| 2 | GE Healthcare Technologies Inc | 24 |
| 3 | Stryker Corp | 20 |
| 4 | GridAI Technologies Corp | 17 |
| 5 | PetVivo Holdings Inc | 17 |
| 6 | Aquestive Therapeutics Inc | 13 |
| 7 | Cornell University | 13 |
| 8 | Institut National de la Santé et de la Recherche Médicale | 12 |
| 9 | University of Alabama System | 11 |
| 10 | Boston University | 9 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 384 |
| 2 | A61P | Therapeutic activity (drug indications) | 234 |
| 3 | A61L | Sterilising / disinfecting materials | 130 |
| 4 | C08L | Polymer compositions (blends) | 106 |
| 5 | A61B | 53 |
| 6 | A61F | 46 | |
| 7 | C07C | Acyclic and carbocyclic compounds | 39 |
| 8 | C07K | Peptides | 36 |
| 9 | C07D | Heterocyclic compounds | 31 |
| 10 | C08F | Polymers from C=C unsaturated bonds | 30 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | 2017 | Wave Life Sciences Pte Ltd | 149 |
| Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors | 2001 | GE Healthcare Technologies Inc | 370 |
| DHA-pharmaceutical agent conjugates of taxanes | 1998 | Daiichi Sankyo Co Ltd | 360 |
| Protein matrix materials, devices and methods of making and using thereof | 2010 | PetVivo Holdings Inc | 198 |
| Modified release composition for highly soluble drugs | 2012 | Torrent Pharmaceuticals Ltd | 164 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 2 |
| 2018 | 1 |
| 2024 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Sviridov Nk | 5 | |
| 2 | Nikitina Rg | 3 | |
| 3 | Robert L. Scanlan | 3 | |
| 4 | Alex Chan | University of Tennessee at Knoxville | 2 |
| 5 | Herman Turndorf | New York University | 2 |
| 6 | Lev Langerman | Columbia University Irving Medical Center | 2 |
| 7 | Mardynskaia Vp | 2 | |
| 8 | J. Lester | Rigshospitalet | 2 |
| 9 | Epstein Bs | 2 | |
| 10 | Trofimov Va | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Neurotoxicity of radiological contrast agents | 1983 | 242 | Traumatic Brain Injury and Neurovascular Disturbances |
| Fish under exercise | 2011 | 183 | Aquaculture Nutrition and Growth |
| Extradural block. Confirmation of the injection site by X‐ray monitoring | 1985 | 164 | Anesthesia and Pain Management |
| Modification of cyanoacrylate for therapeutic embolization: preliminary experience | 1979 | 119 | Trauma Management and Diagnosis |
| Long-Term Outcome of Embolotherapy and Surgery for High-Flow Extremity Arteriovenous Malformations | 2000 | 116 | Vascular Malformations and Hemangiomas |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and structure of Iophendylate?
Which organizations hold the most patents related to Iophendylate?
What is the current patent and publication activity for Iophendylate?
What are the primary patent classifications associated with Iophendylate inventions?
What research topics are associated with published papers on Iophendylate?